Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2008-08-12

FDA Approved: THYROGEN — Supplemental Application (Genzyme Corporation)

View source ↗

Summary

FDA approved a supplemental labeling for THYROGEN (thyrotropin alfa) by Genzyme Corporation, expanding/modifying its indications for use in diagnostic imaging a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Thyrogen (thyrotropin alfa)

Snippet

SUPPL AP for THYROGEN (THYROTROPIN ALFA)